IFIH1 and clinically amyopathic dermatomyositis: Therefore, in this study, we retrospectively analyzed MI in a large group of hospitalized anti-MDA5 Ab+ DM/CADM patients to identify the risk factors for occurrence of MI and to explore whether MI is a prognostic factor in these patients.